• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺纤维化中的阻塞性睡眠呼吸暂停。

Obstructive sleep apnea in pulmonary fibrosis.

机构信息

Department of Respiratory Medicine, Sleep Disorders Center, University General Hospital, Medical School of the University of Crete.

Department of Respiratory Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.

出版信息

Curr Opin Pulm Med. 2020 Sep;26(5):443-448. doi: 10.1097/MCP.0000000000000697.

DOI:10.1097/MCP.0000000000000697
PMID:32701670
Abstract

PURPOSE OF REVIEW

In previous years, there was limited research related to the role of sleep in interstitial lung diseases (ILDs). Physicians treating ILD patients tended to focus mainly on the daily disabling symptoms overlooking the possible significant role of coexisting sleep disorders, such as obstructive sleep apnea (OSA). However, recently, there has been a growing interest in OSA in ILDs, as well as OSA effect on sleep, life quality and outcome in these patients with emphasis on idiopathic pulmonary fibrosis (IPF).

RECENT FINDINGS

OSA has been recognized as an important, high-prevalence comorbidity for the diagnosis and management of IPF. This publication provides a summary of the most relevant recent evidence with regard to OSA in various ILDs and especially IPF, including prevalence, clinical presentation, complications, screening and diagnosis. It also provides updated evidence on the role of OSA therapy in improving sleep, quality of life and disease outcome.

SUMMARY

It is too early to characterize OSA and ILDs association as an 'overlap' syndrome. In depth research is needed, including studies with large numbers of ILDs and IPF patients. The main priority is to increase the awareness among physicians for early diagnosis of OSA in ILDs patients.

摘要

综述目的: 近年来,关于睡眠在间质性肺疾病(ILDs)中的作用的研究有限。治疗ILD 患者的医生往往主要关注日常致残症状,而忽略了共存的睡眠障碍(如阻塞性睡眠呼吸暂停(OSA))可能产生的重要影响。然而,最近人们对 OSA 在 ILD 中的作用以及 OSA 对这些患者的睡眠、生活质量和预后的影响越来越感兴趣,重点是特发性肺纤维化(IPF)。

最近的发现: OSA 已被认为是诊断和管理 IPF 的重要且高发的合并症。本文总结了有关各种 ILD 尤其是 IPF 中 OSA 的最新研究证据,包括患病率、临床表现、并发症、筛查和诊断。它还提供了关于 OSA 治疗改善睡眠、生活质量和疾病结局的最新证据。

总结: 目前将 OSA 和 ILD 的相关性描述为一种“重叠”综合征还为时过早。需要进行深入研究,包括对大量 ILD 和 IPF 患者进行研究。当务之急是提高医生对ILD 患者 OSA 早期诊断的认识。

相似文献

1
Obstructive sleep apnea in pulmonary fibrosis.肺纤维化中的阻塞性睡眠呼吸暂停。
Curr Opin Pulm Med. 2020 Sep;26(5):443-448. doi: 10.1097/MCP.0000000000000697.
2
Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis.睡眠作为改善特发性肺纤维化预后的新靶点。
Chest. 2017 Dec;152(6):1327-1338. doi: 10.1016/j.chest.2017.07.019. Epub 2017 Aug 1.
3
First Description of the Hyperpnea-Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting.特发性肺纤维化-阻塞性睡眠呼吸暂停患者过度通气-低通气周期呼吸的首次描述:真实环境下的治疗意义。
Int J Environ Res Public Health. 2019 Nov 26;16(23):4712. doi: 10.3390/ijerph16234712.
4
Obstructive sleep apnea in patients with interstitial lung disease: Prevalence and predictive factors.特发性肺纤维化患者阻塞性睡眠呼吸暂停:患病率和预测因素。
PLoS One. 2020 Oct 5;15(10):e0239963. doi: 10.1371/journal.pone.0239963. eCollection 2020.
5
Prevalence and clinical impacts of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: A single-center, retrospective study.特发性肺纤维化患者阻塞性睡眠呼吸暂停的患病率及临床影响:一项单中心回顾性研究。
PLoS One. 2023 Sep 26;18(9):e0291195. doi: 10.1371/journal.pone.0291195. eCollection 2023.
6
Risk of obstructive sleep apnea in idiopathic pulmonary fibrosis.特发性肺纤维化患者发生阻塞性睡眠呼吸暂停的风险
Eur J Intern Med. 2023 Apr;110:120-121. doi: 10.1016/j.ejim.2022.12.010. Epub 2022 Dec 22.
7
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.基于聚类的分析评估纤维化间质性肺疾病合并症的影响。
Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7.
8
Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis.特发性肺纤维化患者中的阻塞性睡眠呼吸暂停及其相关合并症。
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.01934-2016. Print 2017 Jun.
9
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.特发性肺纤维化与睡眠障碍:不再是夜间的陌生人。
Eur Respir Rev. 2015 Jun;24(136):327-39. doi: 10.1183/16000617.00009114.
10
Diagnosing complications and co-morbidities of fibrotic interstitial lung disease.诊断纤维化间质性肺疾病的并发症和合并症。
Expert Rev Respir Med. 2019 Jul;13(7):645-658. doi: 10.1080/17476348.2019.1632196. Epub 2019 Jul 5.

引用本文的文献

1
The Role of Obstructive Sleep Apnea in Pulmonary Hypertension Associated with Lung Diseases (Group 3 Pulmonary Hypertension): A Narrative Review.阻塞性睡眠呼吸暂停在与肺部疾病相关的肺动脉高压(第3组肺动脉高压)中的作用:一篇叙述性综述
J Clin Med. 2025 Aug 1;14(15):5442. doi: 10.3390/jcm14155442.
2
Cough in idiopathic pulmonary fibrosis: what is new.特发性肺纤维化中的咳嗽:有哪些新进展。
Breathe (Sheff). 2025 Apr 17;21(2):240176. doi: 10.1183/20734735.0176-2024. eCollection 2025 Apr.
3
Obstructive sleep apnea in patients with fibrotic interstitial lung disease (non-idiopathic pulmonary fibrosis): what should be offered?
纤维化间质性肺疾病(非特发性肺纤维化)患者的阻塞性睡眠呼吸暂停:应提供什么治疗?
J Bras Pneumol. 2024 Dec 6;50(5):e20240058. doi: 10.36416/1806-3756/e20240058. eCollection 2024.
4
KL‑6, ET‑1 and S100A9 levels in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea.特发性肺纤维化和阻塞性睡眠呼吸暂停患者的KL-6、ET-1和S100A9水平
Exp Ther Med. 2024 Nov 18;29(1):16. doi: 10.3892/etm.2024.12766. eCollection 2025 Jan.
5
Idiopathic Pulmonary Fibrosis: Review of Current Knowledge.特发性肺纤维化:现有知识综述。
Physiol Res. 2024 Aug 31;73(4):487-497. doi: 10.33549/physiolres.935322.
6
Intermittent hypoxia induces myofibroblast differentiation and extracellular matrix production of MRC5s via HIF-1α-TGF-β/Smad pathway.间歇性低氧通过 HIF-1α-TGF-β/Smad 通路诱导 MRC5 成肌纤维细胞分化和细胞外基质产生。
Sleep Breath. 2024 Mar;28(1):291-300. doi: 10.1007/s11325-023-02889-y. Epub 2023 Sep 12.
7
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease.可治疗特征:间质性肺病的综合精准医疗方法。
Eur Respir J. 2023 Jul 27;62(1). doi: 10.1183/13993003.00404-2023. Print 2023 Jul.
8
Causal associations between obstructive sleep apnea and COVID-19: A bidirectional Mendelian randomization study.阻塞性睡眠呼吸暂停与 COVID-19 之间的因果关系:一项双向孟德尔随机化研究。
Sleep Med. 2023 Jan;101:28-35. doi: 10.1016/j.sleep.2022.09.013. Epub 2022 Oct 13.
9
OSA and Chronic Respiratory Disease: Mechanisms and Epidemiology.阻塞性睡眠呼吸暂停与慢性呼吸系统疾病:发病机制与流行病学。
Int J Environ Res Public Health. 2022 Apr 30;19(9):5473. doi: 10.3390/ijerph19095473.
10
Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside.非病毒基因疗法治疗肺纤维化:从实验台到病床边
Pharmaceutics. 2022 Apr 7;14(4):813. doi: 10.3390/pharmaceutics14040813.